These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23685297)

  • 1. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial.
    Ormiston JA; Watson T; van Pelt N; Stewart R; Stewart JT; White JM; Doughty RN; Stewart F; Macdonald R; Webster MW
    EuroIntervention; 2013 May; 9(1):70-4. PubMed ID: 23685297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symplicity multi-electrode radiofrequency renal denervation system feasibility study.
    Whitbourn R; Harding SA; Walton A
    EuroIntervention; 2015 May; 11(1):104-9. PubMed ID: 25982652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional management in hypertension: where do we stand?
    Townsend RR
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):444-8. PubMed ID: 25061991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.
    Mabin T; Sapoval M; Cabane V; Stemmett J; Iyer M
    EuroIntervention; 2012 May; 8(1):57-61. PubMed ID: 22580249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant Hypertension.
    Chernin G; Szwarcfiter I; Scheinert D; Blessing E; Diehm N; Dens J; Walton A; Verheye S; Shetty S; Jonas M
    J Vasc Interv Radiol; 2018 Aug; 29(8):1158-1166. PubMed ID: 29921526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
    Id D; Kaltenbach B; Bertog SC; Hornung M; Hofmann I; Vaskelyte L; Sievert H
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension.
    Ott C; Schmid A; Toennes SW; Ditting T; Veelken R; Uder M; Schmieder RE
    EuroIntervention; 2015 May; 11(1):110-6. PubMed ID: 25982653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in the treatment of severe drug resistant hypertension.
    Lobodzinski SS
    Cardiol J; 2011; 18(6):707-11. PubMed ID: 22113765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.
    Al Raisi SI; Pouliopoulos J; Qian P; King P; Byth K; Barry MT; Swinnen J; Thiagalingam A; Kovoor P
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E105-E111. PubMed ID: 30549404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Externally Delivered Focused Ultrasound for Renal Denervation.
    Neuzil P; Ormiston J; Brinton TJ; Starek Z; Esler M; Dawood O; Anderson TL; Gertner M; Whitbourne R; Schmieder RE
    JACC Cardiovasc Interv; 2016 Jun; 9(12):1292-1299. PubMed ID: 27339848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension.
    Khalid N; Rogers T; Shlofmitz E; Chen Y; Dan K; Torguson R; Weintraub WS; Waksman R
    Cardiovasc Revasc Med; 2019 Oct; 20(10):891-896. PubMed ID: 31447315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.